Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This comprehensive report provides valuable insights into the global nuclear medicine market, including market size, growth trends, regional analysis, and key developments.
Market Overview:
The global nuclear medicine market grew from $6.79 billion in 2022 to $7.71 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%. The market is projected to reach $12.34 billion in 2027 at a CAGR of 12.5%. The nuclear medicine market includes sales of various diagnostic and therapeutic services, such as bone density scanning, cardiac PET perfusion, and cardiac PET sarcoid.
Key Drivers and Trends:
The increasing prevalence of cardiovascular diseases (CVDs) and cancer is expected to propel the growth of the nuclear medicine market. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly, while nuclear medicine therapy is used to treat cancer. Product innovation is another key trend in the market, with major companies focusing on developing new and innovative products to strengthen their position.
Regional Analysis:
North America was the largest region in the nuclear medicine market in 2022, while Asia-Pacific is expected to be the fastest-growing region in the forecast period. The report covers key regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Key Questions Answered:
- Where is the largest and fastest-growing market for nuclear medicine ?
- How does the market relate to the overall economy, demography and other similar markets?
- What forces will shape the market going forward?
- The nuclear medicine market global report answers all these questions and many more.
Key Players
- Bracco Imaging S.P.A.
- Lantheus Medical Imaging Inc.
- NTP Radioisotopes SOC Ltd
- Eckert & Ziegler Group
- Jubilant Pharma LLC
- Australian Nuclear Science & Technology Organization
- Cardinal Health Inc
- GE Healthcare
- Curium Pharma7
- Advanced Accelerator Applications
- Nordion Inc.
- The Institute for radioelements
- Eczacibasi-Monrol
- Siemens Healthineers AG
- Cambridge Isotope Laboratories Inc.
Reasons to Purchase:
- Gain a comprehensive understanding of the nuclear medicine market with in-depth analysis of current and future scenarios.
- Identify growth segments and investment opportunities.
- Stay ahead of the competition with forecast data and analysis.
- Benchmark performance against key competitors
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $7.71 billion |
| Forecasted Market Value (USD) by 2027 | $12.34 billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/xl4iph
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
